Company
Invoke Bio
Delivering the future of personalized medicine, today.
Also known as Invoke Bio, Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Customers
- a patient seeking access to our expanded access program, or a biopharma company, diagnostics firm, or research institution
- Legal name
- Invoke Bio, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Invoke Bio uses proprietary AI technology to develop 100% custom tailored immunotherapies for people living with cancer.
Funding snapshot
- Total raised
- $100KSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Grant, $100K2026-04
Funding rounds
- Grant
- $100K2026-04, Company stated
Loading relationship preview